NCT01477528

Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)

Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II LVAS (TRACE)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 201 (actual)
• Sponsor: Abbott Medical Devices · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The purpose of this observational study is to obtain multi-center data on HeartMate II (HMII) patients managed with reduced anticoagulation or anti-platelet regimes, and the incidence of thrombotic and bleeding adverse events associated with these regimes.

Conditions

• Anticoagulation
• Left Ventricular Assist Device

Timeline

• Start date: 2011-11-01
• Primary completion: 2015-07-01
• Completion: 2015-08-01
• First posted: 2011-11-22
• Last updated: 2022-06-24

Locations

18 sites across 5 countries: United States, Austria, Czechia, France, Germany